ARTICLE | Clinical News
Viekirax regulatory update
March 16, 2015 7:00 AM UTC
AbbVie submitted an NDA to Japan’s Ministry of Health, Labor and Welfare (MHLW) for an all-oral, interferon-free treatment of ombitasvir/paritaprevir/ritonavir to treat chronic HCV genotype 1 infectio...